What is the main business of WSD Medi Clinical?

The main business activity of WSD Medi Clinical focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 6, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Kępna 15, 03-730 Warszawa.

Who is on the management board?

The management board includes Cezary Adam Szczylik (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 350,000 (approx. $94,543).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $147,341, representing an increase of 10016.2% compared to 2023.

No, the company recorded a net loss of $23,358 in 2024. For comparison, in 2023 the loss was $73,563, meaning the company reduced its loss by 69.8%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $131,676 in 2024, representing 81% of all operating expenses.

WSD Medi Clinicalsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-11-06

Share capital

350,000.00 PLN

Registered address

ul. Kępna 15/19, 03-730 Warszawa, Poland

Electronic delivery address

AE:PL-80177-33303-DATAH-14

Financials

Revenue history (in k)

Filing timeliness

1 of 3 financial statements was filed late (for 2023, 261 days late).

202506/07/2026
202415/05/2025
202302/04/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 299.70kMedianUSD 443.18kAverageUSD 1.74m

Net profit

This companyUSD -43.16kMedianUSD 14.27kAverageUSD 128.63k

Operating costs

This companyUSD 331.36kMedianUSD 395.77kAverageUSD 1.56m

Assets

This companyUSD 137.88kMedianUSD 173.69kAverageUSD 1.02m

Industry

Authorized Representatives

Cezary Adam Szczylik – Management Board Member

Anna Drozd – President of the Management Board

Anna Waśko Grabowska – Management Board Member

Manner of representation

The company is represented externally by all members of the management board independently; however, if the management board consists of at least 3 (three) persons, this authority is vested in 2 (two) members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Anna Drozdage 39	34	$32,144.79	34%
Cezary Adam Szczylikage 74	33	$31,199.35	33%
Anna Katarzyna Waśko Grabowskaage 47	33	$31,199.35	33%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-02-12.

mBank
06 1140 2004 0000 3112 2316 5841
mBank
07 1140 2004 0000 3302 8310 0119

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl